Results 221 to 230 of about 22,249,811 (294)

The role of PD‑1/PD‑L1 axis in liver diseases. [PDF]

Clin Exp Med
Zeng Z, Chen S, Niu Q, Dong H, Yao Y, Wang K, Gong X, Li H.   +7 more
europepmc   +1 more source

Application of Ibuprofen Sodium Dihydrate for Thermochemical Energy Storage

Advanced Functional Materials, EarlyView.
Ibuprofen sodium dihydrate is introduced as a durable organic salt hydrate for low‐temperature thermochemical energy storage, operating within 60°C–110°C with high energy density. At the material level, it delivers ∼99.9% cycling efficiency over 150 cycles without deliquescence, enabled by a dual energy‐storage mechanism coupling dehydration and phase ...
Kavin Chakravarthy Thangaraj, Hannah F. Chang, Shannon J. Lee, Mark E. Bowden, J. David Bazak, Vaithiyalingam Shutthanandan, Venkateshkumar Prabhakaran, Xiao Zhang, David M. Reed, Ajay S. Karakoti, Vijayakumar Murugesan   +10 more
wiley   +1 more source

Circulating PD-1⁺ effector memory T cells predict anti-PD-1 efficacy in advanced gastric cancer. [PDF]

Front Immunol
Wang K, Shao J, Xin K, Zhang L, Liu B, Chen W, Liu Q.   +6 more
europepmc   +1 more source

Multifunctional Gold Nanocluster‐Based PROTAC System for Targeted Degradation of Phosphorylated Tau and Modulation of Neuroinflammation in Alzheimer's Disease

Advanced Functional Materials, EarlyView.
We present a novel proteolysis‐targeting chimera (PROTAC) system conjugated to lipoic acid gold nanoclusters (PLANC), designed to degrade pTau, regulate inflammatory signaling, and effectively traverse the blood‐brain barrier (BBB). PLANC degraded pTau at various phosphorylation sites, with mechanistic studies confirming proteasome‐mediated degradation
Sarah Nevins, Callan D. McLoughlin, Wan‐Kyu Ko, Hye Kyu Choi, Brandon Conklin, Joshua B. Stein, Yannan Hou, Hongwon Kim, Rohan Khulbe, Ki‐Bum Lee   +9 more
wiley   +1 more source

Emerging evidence for anti-PD-1 and IFN-γ as adjunctive immunotherapy in invasive mold infections. [PDF]

mBio
Serris A, Guihot A, Joffre J, Dessajan J, Dahuron L, Bosch A, Dudoignon E, Pierot L, Lelièvre L, Lukaszewicz AC, Monneret G, Lambotte O, Martin-Blondel G, Lanternier F.   +13 more
europepmc   +1 more source

Coupling Anodic Activity and Stability at Ni‐Based Non‐Oxide Catalysts via Coordinating Alcohol Oxidation and Oxygen Evolution

Advanced Functional Materials, EarlyView.
A cooperative and competitive interrelationship between alcohol oxidation (AOR) and water oxidation (OER) was observed on a typical anode catalyst of Ni2P. In situ Raman spectroscopy and electrochemical analyses revealed a specific complementary mechanism between them, in which OER and AOR critically contribute to the activity and stability of anodic ...
Yong Yan, Xinyu Liu, Yuguo Zhao, Hanwen Jian, Huan Zhou, Riyi Zhang, Dong Wang, Peter Schaaf, Lihua Wang, Guangsheng Guo, Xiayan Wang   +10 more
wiley   +1 more source

The role of tumor metabolic reprogramming in acquired anti-PD-1/PD-L1 resistance. [PDF]

Transl Lung Cancer Res
Gao C, Chen J, Pang B, Su C.
europepmc   +1 more source

PD-1 inhibition enters the frontline [PDF]

Nature Reviews Clinical Oncology, 2019
openaire   +2 more sources

Support‐Controlled Reaction Pathways via Dynamic Sulfur‐Mediated Interfaces for Selective Urea Electrolysis

Advanced Functional Materials, EarlyView.
Sulfur‐doped graphitized carbon nanofibers act as adaptive catalyst–support platforms, enabling dynamic sulfur‐mediated reconstruction and strong metal–support interactions. This unique behavior enhances catalyst stability and controls reaction pathways, achieving highly selective urea oxidation (∼92% N2) coupled with efficient hydrogen evolution ...
Melanie Guillén‐Soler, Lucía Vizcaíno‐Anaya, Ahmad Tayyebi, José Manuel Vila‐Fungueiriño, María del Carmen Giménez‐López   +4 more
wiley   +1 more source

Rapid progression to toxic epidermal necrolysis following switch of PD-1 inhibitors: a case report. [PDF]

Front Med (Lausanne)
Huang M, Guan Y, Yang Z.
europepmc   +1 more source